Synlait Special Shareholders’ Meeting update

NZX Code: ATM
ASX Code: A2M


The a2 Milk Company Limited
www.thea2milkcompany.com

6 September 2024
NZX/ASX Market Release
Synlait Special Shareholders’ Meeting update

The a2 Milk Company Limited notes the announcement made today by Synlait Milk Limited (Synlait – NZX: SML; ASX:
SM1) advising that no further action will be taken in relation to the complaint received regarding Synlait’s special
shareholders’ meeting and that the meeting will proceed as scheduled on Wednesday 18 September 2024 at 9.00am.

A copy of Synlait’s announcement is attached.


Authorised for release by the Board of Directors

David Bortolussi
Managing Director and CEO
The a2 Milk Company Limited

For further information, please contact:

Investors / Analysts
David Akers
Group Head of Investor Relations
M +61 412 944 577
david.akers@a2milk.com



Media – New Zealand
Barry Akers
M +64 21 571 234
barryakers9@gmail.com
Media – Other markets
Rick Willis
M +61 411 839 344
rick@networkfour.com.au

 
Synlait Milk Limited · 1028 Heslerton Road, RD13 Rakaia, Canterbury, New Zealand · +643 373 3000 · www.synlait.com



NZX: SML
ASX: SM1
6 September 2024
Synlait confirms complaint dismissed

Synlait Milk Limited (Synlait) advises that NZ RegCo and the Takeovers Panel have confirmed that no
further action is being taken in relation to the complaint received regarding the special shareholders’
meeting.

In connection with this:

(a) NZ RegCo has issued a ruling in relation to the application of Listing Rules 5.2.1 and 6.3.1 to the
proposed issuance of shares to Bright Dairy Holding Limited (Bright) and the proposed
issuance of shares to The a2 Milk Company Limited (a2MC) and the settlement of disputes with
a2MC and A2 Infant Nutrition Limited; and

(b) the Takeovers Panel has issued a media release stating that it has declined to call a section 32
meeting under the Takeovers Act 1993 and, based on the information before it, will not take
any further action in relation to this matter at this stage.

The special shareholders’ meeting will proceed as scheduled on Wednesday 18 September 2024 at
9.00am. a2MC is eligible to vote on the ordinary resolution relating to the proposed issuance to Bright,
and Bright is eligible to vote on the ordinary resolution relating to the issuance to a2MC and the
settlement with a2MC and A2 Infant Nutrition Limited.

The support of all shareholders remains essential to safeguard the future of Synlait, and all
shareholders are encouraged to exercise their right to vote at this important meeting.

Shareholders can vote in person at the meeting or lodge their proxy appointment online at
www.investorvote.co.nz. The deadline for returning proxy votes is 9.00am on Monday 16 September
2024.

For further background on the notice of complaint received regarding the special shareholders’
meeting please see the Synlait announcement released on 28 August 2024.

For more information contact:
Media
Jo Scott
Communications Lead
P: +64 021 883 123
E: jo.scott@synlait.com

Investors
Hannah Lynch
Head of Strategy & Corporate Affairs
P: +64 021 252 8990
E: hannah.lynch@synlait.com